A comparative study of monosaccharide composition analysis as a carbohydrate test for biopharmaceuticals.

Research paper by Akira A Harazono, Tetsu T Kobayashi, Nana N Kawasaki, Satsuki S Itoh, Minoru M Tada, Noritaka N Hashii, Akiko A Ishii, Teruyo T Arato, Shigehiro S Yanagihara, Yuki Y Yagi, Akiko A Koga, Yuriko Y Tsuda, Mikiko M Kimura, Masashi M Sakita, Satoshi S Kitamura, et al.

Indexed on: 10 May '11Published on: 10 May '11Published in: Biologicals


The various monosaccharide composition analysis methods were evaluated as monosaccharide test for glycoprotein-based pharmaceuticals. Neutral and amino sugars were released by hydrolysis with 4-7N trifluoroacetic acid. The monosaccharides were N-acetylated if necessary, and analyzed by high-performance liquid chromatography (HPLC) with fluorometric or UV detection after derivatization with 2-aminopyridine, ethyl 4-aminobenzoate, 2-aminobenzoic acid or 1-phenyl-3-methyl-5-pyrazolone, or high pH anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD). Sialic acids were released by mild acid hydrolysis or sialidase digestion, and analyzed by HPLC with fluorometric detection after derivatization with 1,2-diamino-4,5-methylenedioxybenzene, or HPAEC-PAD. These methods were verified for resolution, linearity, repeatability, and accuracy using a monosaccharide standard solution, a mixture of epoetin alfa and beta, and alteplase as models. It was confirmed that those methods were useful for ensuring the consistency of glycosylation. It is considered essential that the analytical conditions including desalting, selection of internal standards, release of monosaccharides, and gradient time course should be determined carefully to eliminate interference of sample matrix. Various HPLC-based monosaccharide analysis methods were evaluated as a carbohydrate test for glycoprotein pharmaceuticals by an inter-laboratory study.